Statistics
Publications
101
Citations
9K
H-Index
36
Active since
2010
Hiroaki Akamatsu is an author at Wakayama Medical University specializing in oncology, medicine, and lung cancer.
Publications per year
2010–2025
101
101
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
Tony Mok, Yi‐Long Wu, Myung‐Ju Ahn et al. · New England Journal of Medicine · 2016 · 3.3K citations · Full text
Medicine, Oncology, Pharmacology +16
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · New England Journal of Medicine · 2023 · 682 citations · Full text
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
Myung‐Ju Ahn, Byoung Chul Cho, Enriqueta Felip et al. · New England Journal of Medicine · 2023 · 482 citations
Medicine, Oncology, Pharmacology +16
Vassiliki A. Papadimitrakopoulou, Tony Mok, Ji‐Youn Han et al. · Annals of Oncology · 2020 · 276 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 101